date,title,source
Oct-22-18,Here's Why Kura Oncology Fell Today,Motley Fool
Oct-22-18,Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC,GlobeNewswire
Oct-23-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Dropbox, Kura Oncology, DHT, Wayfair, US Foods Holding, and InflaRx N.V  New Research Emphasizes Economic Growth",GlobeNewswire
Oct-25-18,3 Beaten-Down Biotech Stocks: Can They Bounce Back?,Motley Fool
Oct-29-18,Kura Oncology to Report Third Quarter 2018 Financial Results,GlobeNewswire
